RxDoctor Payments Data

Callie Williams

Acute Care · Birmingham, ALNPI 1508275298

Payments from drug & device makers

$825in general payments, 2019–2025

Across 41 payments — averaging $20.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$176
  • Johnson & Johnson$123
  • Merck$102
  • Astellas Pharma US Inc$53
  • Amgen$48
  • AstraZeneca$44
  • plus $279 from 11 others

What the payments were for

  • Food & beverage$77294%
  • Education$536%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$825 in reported general payments places this provider in the 60th percentile of 711 acute care providers in Alabama.

See all acute care providers in Alabama

Medicare billing

Part B allowed, 2024
$36,847
Medicare patients
292
Services billed
655

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin81$55,529
EliquisApixaban76$54,513
XareltoRivaroxaban17$18,238
Repatha SureclickEvolocumab19$12,580
FarxigaDapagliflozin Propanediol11$5,993
Metoprolol Succinate189$1,950
Flecainide Acetate34$1,637
Atorvastatin Calcium101$1,477
Bumetanide56$1,381
Ranolazine ErRanolazine15$930
Rosuvastatin Calcium37$724
Valsartan11$687
ClopidogrelClopidogrel Bisulfate70$673
Amlodipine Besylate98$548
Hydralazine Hcl39$469

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$38$55,52981 claims
PfizerEliquis$37$54,51376 claims
Johnson & JohnsonXarelto$123$18,23817 claims
AstraZenecaFarxiga$44$5,99311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 711 acute care providers in Alabama.

Other acute care in Birmingham

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →